Similarly, there were trends toward a significant reduction in TIM-3 and LAG-3 expression on the surface of tumour-infiltrating CD4+ T cells post-FLOT and post-CROSS chemoradiotherapy. The gene discussed is CD4; the disease is neoplasm.